We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA and CTTI Launch Patient Forum to Boost Engagement in Drug Development
FDA and CTTI Launch Patient Forum to Boost Engagement in Drug Development
The Patient Engagement Collaborative is gearing up for a launch in early 2018. The new, external panel is being built by the FDA and the Clinical Trials Transformation Initiative (CTTI), a public-private partnership between the FDA and Duke University.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor